Please login to the form below

Not currently logged in
Email:
Password:

EUSA Pharma adds William Crouse to board of directors

Comes as firm hopes to become global leader in biotechnology

EUSA Pharma has appointed William Crouse to its board of directors.

Crouse joins with 50 years of experience in the life sciences industry with his most recent role being general partner at Healthcare Venture, one of the world's largest venture capital firms specialising in biotechnology.

Prior to this, in his many roles over 30 years he has worked in the diagnostics industry, international operations, strategic planning, acquisitions, new product development and sales and marketing.

He said: “It's an honour to join EUSA and to help this ambitious company become a major force in the speciality field.

“Having worked with many of the EUSA team previously, I am confident the company has the capabilities and infrastructure in place to rapidly become a leading player in the sector.”

Bryan Morton, executive chairman at EUSA Pharma, said: “We have great ambitions for EUSA, and plan to grow our existing profitable business through acquisition and in-licensing.

“Bill's extensive experience and strategic insight will be a huge asset as we transform our business into a leading transatlantic speciality commercialization company.”

9th September 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics